JFGIW
CLDX icon

Johnson Financial Group Inc (Wisconsin)’s Celldex Therapeutics CLDX Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20
Closed -$3K – 787
2015
Q3 		$3K Hold
20
– – ﹤0.01% 735
2015
Q2 		$8K Hold
20
– – ﹤0.01% 698
2015
Q1 		$8K Buy
+20
New +$7.16K ﹤0.01% 699

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s CLDX Position: Q4 2015 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Celldex Therapeutics (CLDX) in Q4 2015, closing a stake of 20 shares — an estimated $3K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in CLDX in Q1 2015 and held it in 3 quarters. The position peaked at $8K in Q2 2015. 171 funds tracked by Wall St. Rank hold CLDX as of Q4 2015.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Celldex Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 20 Celldex Therapeutics shares in Q4 2015, an estimated $3K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Celldex Therapeutics in Q1 2015 and held it in 3 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Celldex Therapeutics position peaked at $8K in Q2 2015.
  • 171 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q4 2015.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q4 2015, filed 8 Feb 2016.